BTI Biotechnology Institute
BTI Biotechnology Institute is a Spanish multinational biomedical company founded by Dr. Eduardo Anitua that develops and sells dental implant systems, PRGF-ENDORET regenerative medicine technology, and sleep apnea devices to dental and medical professionals across 40+ countries.
- Company typePrivate
- Founded1999
- HeadquartersVitoria-gasteiz, Spain
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What BTI Biotechnology Institute does
BTI Biotechnology Institute is a Spanish multinational biomedical company founded in the mid-1990s by Dr. Eduardo Anitua and headquartered in Vitoria-Gasteiz, Spain, operating across three specialized fields: oral implantology, regenerative medicine, and sleep apnea. Its core technology platform is PRGF-ENDORET, a closed-system plasma rich in growth factors technology for tissue regeneration backed by over 200 indexed scientific publications, complemented by the BTI Implant System (with Extra-Short, TINY, and Wide Platform designs plus Ti-Black and Ti-Golden surface treatments) and the BioBlock prosthetic concept. The portfolio also includes the BTI APNiA sleep apnea diagnosis and treatment device, the HTL CAD/CAM laboratory subsidiary for digital prosthetic manufacturing, and AI-assisted HTL Unloading Splints for TMD treatment.
The company employs over 300 people with approximately 20% dedicated to R&D, operates seven wholly-owned regional subsidiaries in Germany, Italy, Portugal, the UK, the US, Mexico, and France, and reaches 40+ countries through an extensive distributor network. Revenue is generated primarily through hardware sales of medical devices and consumables (dental implants, PRGF kits, prosthetic components, CAD/CAM prostheses, sleep apnea devices), supplemented by professional training services delivered through the BTI Training Center and Eduardo Anitua Institute. The go-to-market combines direct field sales via Territory Managers with international distributor relationships, supported by scientific publication output, congress participation, and training partnerships with professional dental associations. Certifications include ISO 13485, MDSAP, EU MDR 2017/745, and CE marking for PRGF-ENDORET.
BTI Biotechnology Institute firmographics
Firmographics- Name
- BTI Biotechnology Institute
- Legal name
- BTI Biotechnology Institute S.L.
- Website
- https://bti-biotechnologyinstitute.com
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- BTI Biotechnology Institute is a Spanish multinational biomedical company founded by Dr. Eduardo Anitua that develops and sells dental implant systems, PRGF-ENDORET regenerative medicine technology, and sleep apnea devices to dental and medical professionals across 40+ countries.
- Ownership category
- akta.pro rank
BTI Biotechnology Institute industry classification
Industry- Product category
- Dental Implants and Regenerative Medicine Devices
- NAICS
- Dental Equipment and Supplies Manufacturing (339114), Dental Laboratories (339116), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Dental Equipment & Supplies (3843), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Dental Implants & Prosthodontic Components (Implants/Abutments/Prosthetics) (HLAHAEAE)
- akta.pro secondary industries
- Implant Prosthetics & Abutment Fabrication (HLABAJAC), Crown & Bridge (Fixed Prosthetics) Fabrication (HLABAJAA)
Keywords
Where BTI Biotechnology Institute is headquartered
LocationHeadquarters
- HQ city
- Vitoria-gasteiz
- HQ country
- Spain
- HQ region
- Europe
Offices10 records
Markets served
BTI Biotechnology Institute business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Dental Implants and Components: Design, manufacture and sale of dental implants, prosthetic components (Square Abutments, transepithelial abutments), and surgical instruments for oral implantology.
- PRGF – ENDORET® Technology Systems: Sale of closed-system kits, equipment and disposable products for obtaining and applying plasma rich in growth factors for regenerative medicine applications.
- CAD/CAM Prosthetic Manufacturing: HTL CAD-CAM laboratory providing design and production solutions for dental prostheses in various materials (Titanium, cobalt-chrome, zirconium, PMMA, lithium disilicate, PEEK, eMax, composite).
- Sleep Apnea Devices: Manufacturing and sale of BTI APNiA® intraoral devices for sleep apnea treatment and diagnostic software.
- Professional Training Services: Training courses, webinars, clinical stays, and continuing education programs for dental and medical professionals through BTI Training Center and Eduardo Anitua Institute.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | One time/ perpetual license | Training courses vary by type and duration |
| Other | Multi-year contract | Medical devices and equipment - quote-based pricing |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
BTI Biotechnology Institute product offering
Product offeringCore offering
BTI Biotechnology Institute designs, manufactures, and sells proprietary biomedical devices and technology systems across three fields: (1) Oral Implantology — the BTI Implant System with specialized geometries (Extra-Short, TINY, Wide Platform) and proprietary Ti-Black/Ti-Golden surface treatments; (2) Regenerative Medicine — the PRGF-ENDORET closed-system plasma rich in growth factors technology and the BioBlock prosthetic concept; and (3) Sleep Apnea — the BTI APNiA intraoral diagnostic and treatment device. The company also operates the HTL CAD/CAM dental laboratory for digital prosthesis production and the Eduardo Anitua Institute for professional training.
Product overview
BTI Biotechnology Institute is a biomedical company operating across three specialized fields: Oral Implantology, Regenerative Medicine, and Sleep Apnea. The core product offering centers on the PRGF – ENDORET® technology platform for tissue regeneration, complemented by the BTI Implant System for dental implantology. The portfolio includes specialized prosthetic components (BioBlock® concept with Square Abutments, Ti-Golden®, Ti-Black® surface treatments, and Scan Bodies), CAD/CAM digital manufacturing through HTL, and AI-assisted HTL Unloading Splints for TMJ treatment. For sleep apnea, BTI offers the APNiA® diagnostic and treatment system. The company also provides professional training services through its dedicated BTI Training Center and Eduardo Anitua Institute.
Differentiator
Problem solved
Functional benefit
Brands
- PRGF – ENDORET®: Proprietary plasma rich in growth factors technology for tissue regeneration used across multiple medical specialties including dentistry, traumatology, dermatology, ophthalmology, and reproductive medicine
- BTI APNiA®
- BioBlock®
- HTL
- HTL Dental Laboratory
- BTI Training Center
- BTI Academy
- BTI Scan
Products and services
- BTI Implant System
- PRGF – ENDORET®
- BioBlock® Prosthetic System
- HTL CAD/CAM Digital Dental Laboratory
- HTL Unloading Splints
- BTI APNiA®
- Guided Surgery System
- BTI Training Center / Eduardo Anitua Institute
Quantifiable outcome
- Over 200 indexed scientific publications supporting PRGF-ENDORET technology
- +2 more outcomes
Companies that use BTI Biotechnology Institute
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
BTI Biotechnology Institute technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature6 records
BTI Biotechnology Institute partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered minor and core.
- Acción Social de Rural KutxaminorCollaboration agreement signed to support training activities and scientific research carried out by the Eduardo Anitua Foundation, contributing to biomedical research, scientific innovation, and knowledge generation with real health impact.
- ARKABIA (Fundación Vital)minorPRGF-Endoret technology featured in the inaugural 'Encrucijada' exhibition showcasing innovative cultural and social projects. BTI's contribution highlights the company's research in regenerative therapies through a centrifuge display and audiovisual area.
- Fundación Dental EspañolacoreCollaboration agreement to contribute to the growth and excellence of dentistry in Spain through specialized training programs accessible to all licensed dentists. The Foundation provides its collegiate infrastructure and training platform for BTI's specific training content.
- Pacto Mundial de la ONU EspañaminorBTI has adhered to the UN Global Compact, committing to align its activity with universally accepted principles in human rights, labor standards, environment, and anti-corruption, supporting the UN Sustainable Development Goals.
- Fundación Tutelar BeroaminorThrough the Eduardo Anitua Foundation, BTI provides free dental treatment to mentally ill individuals under Beroa Foundation guardianship who lack economic resources. Collaboration spans over 10 years.
- Alianza para la Vacunación Infantil (Fundación la Caixa, Gavi)coreThrough the Eduardo Anitua Foundation, BTI participates in the Childhood Vaccination Alliance created by Fundación la Caixa and Gavi. The alliance multiplies each donation by four (with Bill and Melinda Gates Foundation participation). BTI's contribution funds pneumococcal vaccine distribution in Mozambique and Ethiopia, contributing to vaccination of over 8 million children under 5.
Scale indicators7 records
Recent moves13 records
Expansion highlights5 records
BTI Biotechnology Institute competitors and assessment
Company assessmentEmerging players
- CGF/Mectron: Producer of PRF (Platelet-Rich Fibrin) centrifuge and consumable systems, the closest technological competitor to BTI's PRGF-ENDORET in autologous growth-factor preparation. Comparable as an adjacent/competing regenerative-technology platform used in dental and maxillofacial procedures.
Direct peers
- Nobel Biocare (Envista): Premium dental implant and prosthodontic components manufacturer, part of Envista Holdings. Comparable as a direct competitor in implants, abutments, and CAD/CAM prosthetic workflows serving oral surgeons and prosthodontists.
- BioHorizons (Henry Schein): U.S.-based dental implant company owned by Henry Schein, with a focus on premium implant systems and regenerative products. Comparable as a specialty implant manufacturer serving periodontists and oral surgeons with similar mid-size scale.
- TBR Dental: French dental implant and prosthetic manufacturer focused on premium European markets. Comparable as a European specialty implant company of similar scale and clinical-scientific positioning.
- Geistlich Pharma: Swiss leader in dental regenerative products (bone substitutes, membranes). Comparable as a focused regenerative dentistry specialist with strong scientific positioning, mirroring BTI's PRGF-ENDORET strategy in oral tissue regeneration.
- MIS Implants Technologies: Mid-market dental implant manufacturer with global distribution, now part of Dentsply Sirona but historically a direct competitor. Comparable as a similarly-sized privately-rooted implant specialist expanding internationally.
- Sweden & Martina: Italy-based mid-sized dental implant and prosthetic components manufacturer with international distribution. Closest size-and-scope peer to BTI — family/privately held European implant specialist with similar product breadth and geographic mix.
- ZimVie (Zimmer Biomet Dental): Dental implant and digital solutions spinoff from Zimmer Biomet. Direct peer in dental implants and regenerative dental materials (bone grafts, membranes) with similar specialty positioning to BTI in oral implantology.
Broad incumbents
- Straumann: Global #1 dental implant company with broad portfolio in implants, prosthetics, digital workflows, and regenerative dentistry. Comparable as the dominant scale player in BTI's core dental implantology market; BTI competes as a premium specialist within Straumann's footprint.
- Dentsply Sirona: Largest diversified dental equipment and supplies manufacturer with implants, imaging, and CAD/CAM. Comparable as broad incumbent with overlapping dental implant and digital workflow offerings; BTI is a focused specialist competing for share within Dentsply's portfolio breadth.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
BTI Biotechnology Institute social profiles
Digital presenceBTI Biotechnology Institute compliance and trust
Trust signalCompliance4 records
BTI Biotechnology Institute financial estimates
Financial estimateRevenue estimate
Valuation estimate
BTI Biotechnology Institute leadership team
Management profileNumber of profiles
Profiles1 record
BTI Biotechnology Institute subsidiaries and ownership
Company hierarchySubsidiaries9 records
BTI Biotechnology Institute funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BTI Biotechnology Institute M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BTI Biotechnology Institute
What does BTI Biotechnology Institute do?
BTI Biotechnology Institute designs, manufactures, and sells proprietary biomedical devices and technology systems across three fields: (1) Oral Implantology — the BTI Implant System with specialized geometries (Extra-Short, TINY, Wide Platform) and proprietary Ti-Black/Ti-Golden surface treatments; (2) Regenerative Medicine — the PRGF-ENDORET closed-system plasma rich in growth factors technology and the BioBlock prosthetic concept; and (3) Sleep Apnea — the BTI APNiA intraoral diagnostic and treatment device. The company also operates the HTL CAD/CAM dental laboratory for digital prosthesis production and the Eduardo Anitua Institute for professional training.
Is BTI Biotechnology Institute a public or private company?
BTI Biotechnology Institute is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was BTI Biotechnology Institute founded?
BTI Biotechnology Institute was founded in 1999. It employs 251 to 500 people.
Where is BTI Biotechnology Institute based?
BTI Biotechnology Institute is headquartered in Vitoria-gasteiz, Spain, in the Europe region.
How does BTI Biotechnology Institute make money?
Five revenue lines are on record. Dental Implants and Components are the primary driver. The others are PRGF – ENDORET® Technology Systems, CAD/CAM Prosthetic Manufacturing, sleep Apnea Devices and professional Training Services.
Who are BTI Biotechnology Institute's main competitors?
CGF/Mectron is listed as an emerging player. Direct peers are Nobel Biocare (Envista), BioHorizons (Henry Schein), TBR Dental, Geistlich Pharma, MIS Implants Technologies, Sweden & Martina and ZimVie (Zimmer Biomet Dental). Broad incumbents are Straumann and Dentsply Sirona.
Does BTI Biotechnology Institute have an API?
No public API is recorded for BTI Biotechnology Institute.
What industry is BTI Biotechnology Institute in?
BTI Biotechnology Institute's product category is Dental Implants and Regenerative Medicine Devices. Its primary akta.pro industry code is HLAHAEAE, Dental Implants & Prosthodontic Components (Implants/Abutments/Prosthetics), with a secondary code of HLABAJAC, Implant Prosthetics & Abutment Fabrication. Its NAICS code is 339114 and its SIC code is 3843.